Beneficial effects of CCL8 inhibition at lipopolysaccharide-induced lung injury

CCL8 (MCP-2) is a chemoattractive cytokine associated with various immune-related pathologies. Recent studies show that CCL8 is significantly stimulated during acute respiratory distress syndrome in severely ill patients with COVID-19, making the inhibition of CCL8 activity a promising treatment. Li...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi, Asieh, Farmaki, Elena, Chavez, Bernardo, Cai, Chao, Kaza, Vimala, Zhang, Youwen, Soltanmohammadi, Elham, Daneshvar, Nina, Chatzistamou, Ioulia, Kiaris, Hippokratis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639378/
https://www.ncbi.nlm.nih.gov/pubmed/36404927
http://dx.doi.org/10.1016/j.isci.2022.105520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639378/
https://www.ncbi.nlm.nih.gov/pubmed/36404927
http://dx.doi.org/10.1016/j.isci.2022.105520

Ejemplares similares